Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Asia Medical and Agricultural Laboratory and Research Center PCL EBITDA Margin % Related Terms
Asia Medical and Agricultural Laboratory and Research Center PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asia Medical and Agricultural Laboratory and Research Center PCL EBITDA Margin % Chart
Asia Medical and Agricultural Laboratory and Research Center PCL Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asia Medical and Agricultural Laboratory and Research Center PCL EBITDA Margin % vs Hardware Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) has a EBITDA Margin % of 30.81% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. This is 25% above median its historical median of 24.57. Over the past decade, Asia Medical and Agricultural Laboratory and Research Center PCL's EBITDA Margin % has ranged from 18.17 to 40.69. According to the industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #64 out of 2471 companies in the Hardware industry, placing it in the top 2.6%.
Is Asia Medical and Agricultural Laboratory and Research Center PCL's EBITDA Margin % too high?
Asia Medical and Agricultural Laboratory and Research Center PCL's current EBITDA Margin % of 30.81% is 25% above median its 10-year median of 24.57. Over the past 10 years, this metric has ranged from a low of 18.17 to a high of 40.69. The Hardware industry median EBITDA Margin % is 7.01. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 30.81% is 339.5% above this industry median. Based on the distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #64 out of 2471 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Asia Medical and Agricultural Laboratory and Research Center PCL has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asia Medical and Agricultural Laboratory and Research Center PCL's EBITDA Margin % compare to COHR and KEYS?
According to the Hardware industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #64 out of 2471 companies for EBITDA Margin %. This places Asia Medical and Agricultural Laboratory and Research Center PCL in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.01. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 30.81% is 339.5% above this benchmark. Historically, Asia Medical and Agricultural Laboratory and Research Center PCL's own EBITDA Margin % has ranged from 18.17 to 40.69 over the past decade. While the company's 10-year median is 24.57 vs. the industry median of 7.01, Asia Medical and Agricultural Laboratory and Research Center PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Hardware company?
The median EBITDA Margin % among Hardware companies is 7.01, based on 2,471 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asia Medical and Agricultural Laboratory and Research Center PCL's current EBITDA Margin % of 30.81% is 339.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. For the Hardware industry, the median EBITDA Margin % is 7.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asia Medical and Agricultural Laboratory and Research Center PCL's current EBITDA Margin % is 30.81%, which is 25% above median its own 10-year median of 24.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asia Medical and Agricultural Laboratory and Research Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿2.55, compared to a current price of ฿3.56 — trading 39.6% above its estimated fair value. The current EBITDA Margin % is 30.81%, which is 25% above median its 10-year median of 24.57 and 339.5% above the Hardware industry median of 7.01. Asia Medical and Agricultural Laboratory and Research Center PCL's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC), the current EBITDA Margin % is 30.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Overvalued in 2026?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL stock appears to be overvalued.
The current stock price of ฿3.56 is trading 39.6% above its estimated GF Value™ of ฿2.55.
GuruFocus considers Asia Medical and Agricultural Laboratory and Research Center PCL to be Significantly Overvalued.
Key valuation signals for BKK:AMARC:
EBITDA Margin %: 30.81% (25% above median its 10-year median of 24.57)
GF Value™: ฿2.55 vs. price of ฿3.56 (39.6% above fair value)
Industry Position: 339.5% above the Hardware median (#64 of 2471)
No single metric tells the full story. See the BKK:AMARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asia Medical and Agricultural Laboratory and Research Center PCL Business Description
Asia Medical and Agricultural Laboratory and Research Center PCL is engaged in providing comprehensive scientific services for the agriculture, food, pharmaceutical and environment sectors including testing, calibration, inspection and certification according to international quality standards. The company geographically operates only in Thailand.
79GF Score
Get the complete analysis for BKK:AMARC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:AMARC has been successfully added to your 
